The expression of Runx2 was significantly higher in the dynamic condition than the OM group on Day 7 (1.65‐fold, p‐0.00077) and Day 14 (1.54‐fold, p = 0.00033). The gene discussed is RUNX2; the disease is ocular melanoma.